493 related articles for article (PubMed ID: 16596424)
1. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
2. Podocalyxin expression in malignant astrocytic tumors.
Hayatsu N; Kaneko MK; Mishima K; Nishikawa R; Matsutani M; Price JE; Kato Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):394-8. PubMed ID: 18639524
[TBL] [Abstract][Full Text] [Related]
3. Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma.
Mishima K; Kato Y; Kaneko MK; Nakazawa Y; Kunita A; Fujita N; Tsuruo T; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 Jun; 111(6):563-8. PubMed ID: 16718353
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors.
Kato Y; Hayatsu N; Kaneko MK; Ogasawara S; Hamano T; Takahashi S; Nishikawa R; Matsutani M; Mishima K; Narimatsu H
Biochem Biophys Res Commun; 2008 May; 369(4):1041-6. PubMed ID: 18329383
[TBL] [Abstract][Full Text] [Related]
5. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
6. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
[TBL] [Abstract][Full Text] [Related]
7. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
[TBL] [Abstract][Full Text] [Related]
8. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
9. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.
Dietzmann K; von Bossanyi P
Zentralbl Pathol; 1994 Nov; 140(4-5):335-41. PubMed ID: 7826981
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.
Yamamoto M; Ikeda K; Ohshima K; Tsugu H; Kimura H; Tomonaga M
Cancer Res; 1997 Jul; 57(13):2799-805. PubMed ID: 9205092
[TBL] [Abstract][Full Text] [Related]
13. Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.
Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
Acta Neuropathol; 2005 Oct; 110(4):402-10. PubMed ID: 16155764
[TBL] [Abstract][Full Text] [Related]
14. Mdr1 mRNA expression differs between grade III astrocytomas and glioblastomas.
Kirches E; Oda Y; Von Bossanyi P; Diete S; Schneider T; Warich-Kirches M; Dietzmann K
Clin Neuropathol; 1997; 16(1):34-6. PubMed ID: 9020393
[TBL] [Abstract][Full Text] [Related]
15. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
[TBL] [Abstract][Full Text] [Related]
17. The role of podoplanin in tumor progression and metastasis.
Raica M; Cimpean AM; Ribatti D
Anticancer Res; 2008; 28(5B):2997-3006. PubMed ID: 19031946
[TBL] [Abstract][Full Text] [Related]
18. Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo.
Yamamoto M; Sawaya R; Mohanam S; Loskutoff DJ; Bruner JM; Rao VH; Oka K; Tomonaga M; Nicolson GL; Rao JS
Cancer Res; 1994 Jul; 54(13):3329-32. PubMed ID: 8012944
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.
Broholm H; Laursen H
APMIS; 2004; 112(4-5):257-63. PubMed ID: 15233640
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
